S

Sarepta Therapeutics
D

SRPT

63.550
USD
0.74
(1.18%)
مغلق
حجم التداول
58,380
الربح لكل سهم
8
العائد الربحي
-
P/E
27
حجم السوق
6,244,225,868
أصول ذات صلة
AMGN
AMGN
-2.15
(-0.76%)
281.20 USD
BIIB
BIIB
2.500
(2.07%)
123.460 USD
BMRN
BMRN
-0.700
(-1.12%)
61.980 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
INCY
INCY
0.500
(0.81%)
62.500 USD
I
IONS
1.100
(3.47%)
32.780 USD
R
RCKT
0.16000
(2.04%)
8.02000 USD
REGN
REGN
15.98
(2.71%)
606.12 USD
VRTX
VRTX
2.22
(0.45%)
500.92 USD
المزيد
الأخبار المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.